IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. [electronic resource]
Producer: 19971030Description: 3266-74 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Disease Progression
- Drug Administration Schedule
- Female
- Humans
- Immunoglobulins -- analysis
- Immunotherapy
- Infusions, Intravenous
- Lymphocyte Subsets
- Lymphoma, B-Cell -- immunology
- Male
- Middle Aged
- Recurrence
- Rituximab
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.